Kenneth Mark Alo
Physician at Weslayan, Houston, TX

License number
Colorado 41739
Issued Date
Jun 19, 2003
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
5318 Weslayan St #182, Houston, TX 77005

Professional information

Kenneth M Alo Photo 1

Dr. Kenneth M Alo, Houston TX - MD (Doctor of Medicine)

Specialties:
Pain Medicine
Address:
17270 Red Oak Dr STE 110, Houston 77090
(281) 537-5355 (Phone)
411 Lantern Bend Dr, Houston 77090
(281) 357-1370 (Phone)
845 Fm 1960 Rd W, Houston 77090
(281) 357-1370 (Phone), (281) 516-7693 (Fax)
837 Cypress Creek Pkwy STE 106, Houston 77090
(281) 357-1370 (Phone)
Kenneth M Alo MD
2211 Norfolk St STE 737, Houston 77098
(281) 357-1370 (Phone)
Certifications:
Anesthesiology, 1994, Pain Medicine, 1996
Awards:
Healthgrades Honor Roll
Languages:
English, Italian
Education:
Medical School
The Texas A&M University System Health Science Center College Of Medicine
Graduated: 1989
Baylor University Medical Center
Graduated: 1990
Baylor Hosps
Graduated: 1993
Meth Hospital Baylor


Kenneth Mark Alo Photo 2

Kenneth Mark Alo, Houston TX

Specialties:
Pain Management Specialist
Address:
845 Cypress Creek Pkwy, Houston, TX 77090
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology, American Board of Anesthesiology Sub-certificate in Pain Medicine (Anesthesiology)


Kenneth Alo Photo 3

Systems, Methods And Apparatus For Treating Cardiac Dysfunction With Neurostimulation

US Patent:
2009031, Dec 24, 2009
Filed:
Jun 22, 2009
Appl. No.:
12/489379
Inventors:
Kenneth M. Alo - Houston TX, US
International Classification:
A61N 1/365, A61N 1/36, A61N 1/362, A61N 1/39
US Classification:
607 4, 607 44, 607 9, 607 18, 607 17
Abstract:
Methods, systems, and apparatus for the treatment of heart failure (both systolic and diastolic), hypertension, and arrhythmia in patients by stimulating one or more nerves, particularly peripheral nerves, using neurostimulation are described. The therapeutic treatment is accomplished by applying electrical signals to at least one or more nerves using cutaneous, subcutaneous, implantable, or catheter-based neurostimulation assemblies, alone or in combination with one or more additional therapy or stimulation devices associated with the patient's heart, and/or with one or more therapeutic drug infusions or therapies, such as immune modulation therapy (IMT).